Max Roessler
Missing prognostic value of soluble PD-1, PD-L1 and PD-L2 in lung cancer patients undergoing chemotherapy - A CEPAC-TDM biomarker substudy.
Geiger K, Jörger M, Roessler M, Hettwer K, Ritter C, Simon K, Uhlig S, Holdenrieder S. Missing prognostic value of soluble PD-1, PD-L1 and PD-L2 in lung cancer patients undergoing chemotherapy - A CEPAC-TDM biomarker substudy. Tumour Biol 2024; 46:S355-S367.
01.01.2024Missing prognostic value of soluble PD-1, PD-L1 and PD-L2 in lung cancer patients undergoing chemotherapy - A CEPAC-TDM biomarker substudy.
01.01.2024Tumour Biol 2024; 46:S355-S367
Geiger Kimberly, Jörger Markus, Roessler Max, Hettwer Karina, Ritter Christoph, Simon Kirsten, Uhlig Steffen, Holdenrieder Stefan
Relevance of tumor markers for prognosis and predicting therapy response in non-small cell lung cancer patients: A CEPAC-TDM biomarker substudy.
Geiger K, Jörger M, Roessler M, Hettwer K, Ritter C, Simon K, Uhlig S, Holdenrieder S. Relevance of tumor markers for prognosis and predicting therapy response in non-small cell lung cancer patients: A CEPAC-TDM biomarker substudy. Tumour Biol 2024; 46:S191-S206.
01.01.2024Relevance of tumor markers for prognosis and predicting therapy response in non-small cell lung cancer patients: A CEPAC-TDM biomarker substudy.
01.01.2024Tumour Biol 2024; 46:S191-S206
Geiger Kimberly, Jörger Markus, Roessler Max, Hettwer Karina, Ritter Christoph, Simon Kirsten, Uhlig Steffen, Holdenrieder Stefan